TrialJournal of endocrinological investigation2025
Efficacy and safety of beinaglutide with continuous subcutaneous infusion in newly diagnosed patients with type 2 diabetes: a randomized, control, open-labeled clinical trial.
Yi Luo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.